PRX-14040

PRX-14040
Clinical data
Other namesPRX14040
Drug classDopamine reuptake inhibitor; Pro-motivational agent
Identifiers
  • 5-(2-(1-(3,4-dichlorophenyl)cyclobutyl)-2-hydroxyethyl)-2-oxa-5-azoniabicyclo[2.2.1]heptane chloride
CAS Number
PubChem CID
Chemical and physical data
FormulaC17H22Cl3NO2
Molar mass378.72 g·mol−1
3D model (JSmol)
  • C1CC(C1)(C2=CC(=C(C=C2)Cl)Cl)C(C[NH+]3CC4CC3CO4)O.[Cl-]
  • InChI=1S/C17H21Cl2NO2.ClH/c18-14-3-2-11(6-15(14)19)17(4-1-5-17)16(21)9-20-8-13-7-12(20)10-22-13;/h2-3,6,12-13,16,21H,1,4-5,7-10H2;1H
  • Key:QAHXUHUHCQYFHC-UHFFFAOYSA-N

PRX-14040 is a selective dopamine reuptake inhibitor that was developed by Prexa Pharmaceuticals. It has 28-fold selectivity for the dopamine transporter over the norepinephrine transporter. Similarly to various other dopamine reuptake inhibitors, the drug has been found to reverse motivational deficits induced by the dopamine depleting agent tetrabenazine in animals.

See also